The Mount Sinai Medical Center Names New Vice-Chair of Department of Urology
David B. Samadi, MD, chief of robotics, is named vice-chair. An expert in robotic prostate surgery, Dr. Samadi specializes in urologic cancers.
David B. Samadi, MD, has been named Vice Chair of the Department of Urology at The Mount Sinai Medical Center. This appointment went into effect on October 6, 2010.
"In his new role, Dr. Samadi will lead the effort to expand the scope of the Department of Urology," said Simon Hall, MD, Professor and Chair of the Department of Urology. "He will provide a special emphasis on building relationships with outside physicians and other medical entities to increase our Department’s market share and presence."
Dr. Samadi is a board-certified urologist and a specialist in the diagnosis and treatment of urologic diseases, kidney cancer, bladder cancer, and prostate cancer. He performs many advanced minimally invasive treatments for prostate cancer, including laparoscopic radical prostatectomy and laparoscopic robotic radical prostatectomy. He is one of the few surgeons in New York State qualified to perform a robotic prostate surgery, using the da Vinci robotic system. He is the first surgeon in the United States to successfully perform a robotic surgery redo, demonstrating his mastery of the da Vinci robotic system and proven ability to medically help patients with low and high risks of prostate cancer.
In 2007, Dr. Samadi joined Mount Sinai as Director of the Division of Robotics and Minimally Invasive Surgery. Since his arrival, he has performed 1,500 radical da Vinci prostatectomies, representing one of the busiest robotic programs in the country. His team’s work has been presented at national and international meetings, highlighting Mount Sinai’s importance exploring the role on minimally invasive surgery as a treatment for a variety of urological problems. In 2010, Mount Sinai’s Department of Urology was ranked in U.S. News & World Report for the first time in its history.
Dr. Samadi recommends frequent PSA screenings in men over 50, sometimes as early as age 40, based on risk factors. He believes that being proactive and diagnosing prostate cancer earlier rather than later is better than active surveillance, or watchful waiting. It can end up being very expensive in both cost and life.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. U.S. News & World Report consistently ranks The Mount Sinai Hospital among the nation's best hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.
For more information, visit www.mountsinai.org. Follow us on Twitter @mountsinainyc